Navigation Links
Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
Date:2/20/2008

7

Interest and

bank charges (52) (68) (202) (133)

Accretion expense (1,183) (550) (15,751) (550)

Change in fair

value of embedded

derivatives 28 - (870) -

Change in fair

value of third

party asset-backed

commercial paper (1,184) - (1,184) -

Foreign exchange

gain (loss) (54) 245 1,130 (280)

Other income 287 282 1,274 1,348

Share of loss

in a company

subject to

significant

influence - (489) (327) (2,440)

Non-controlling

interest - 162 109 801

-------------------------------------------------------------------------

Net loss ($16,097) ($17,011) ($81,486) ($66,469)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Net loss per share:

Basic and diluted ($0.33) ($0.44) ($1.85) ($1.72)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Weighted average

number of

common shares

outstanding 48,896,595 38,845,937 44,030,474 38,654,063

-------------------------------------------------------------------------

-------------------------------------------------------------------------

At At

December 31 December 31

Consolidated Balance
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
2. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
3. Neurochem to present at JPMorgan Healthcare Conference
4. Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
5. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
6. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
7. Neurochem reports results for third quarter of fiscal 2007
8. Emageon Reports Fourth Quarter and 2007 Financial Results
9. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
10. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Kathleen Doheny HealthDay ... The U.S. obesity epidemic is a driving force behind the ... study. Researchers looked at data from five national surveys ... increase in diabetes over time could be explained by factors ... U.S. adults. The investigators found that the prevalence of ...
(Date:9/2/2014)... (HealthDay News) -- Melatonin supplements did not reduce delirium ... new study found. Many older hospital patients experience ... disruption of their normal sleep-wake cycle. A lack of ... to delirium, but there has been little research into ... study included 378 patients, average age 84, who had ...
(Date:9/2/2014)... -- Drinking and marijuana may lead to different types ... Researchers analyzed 2007 to 2011 data gathered from ... they had used alcohol or marijuana at least once. ... with more unsafe driving, damage to relationships with friends ... the influence of alcohol, especially among females. ...
(Date:9/2/2014)... in locations with less intensive (and expensive) practice patterns ... that spare patients unnecessary and excessive medical care, according ... . , "Growing concern about the costs and harms ... ability to avoid the provision of unnecessary care," said ... and The Dartmouth Institute for Health Policy & ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Evolve ... within the primary and urgent care arena, is ... opening coincides with a health fair the clinic ... incorporating technology to assist patients in achieving high ... Medical Clinics’ pricing structure is a groundbreaking change ...
Breaking Medicine News(10 mins):Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 3Health News:Booze, Pot Bad for Teens in Different Ways, Study Suggests 2Health News:Residency training predicts physicians' ability to practice conservatively 2Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 2Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 3
... the Nature review website, provides evidence of a ... of these stem cells to treat humans, through perspective gene ... produce cells with stem cell properties, by using specialized and ... ,iPS, stem cells are said to be "pluripotent,: they can ...
... have received nearly $13 million from the National Institutes ... of terrorist attacks, wartime use of toxic gases, and/or ... studies will be ,mustard gas, (sulfur mustard) and chlorine ... they are designed to provide rescue treatments," said Carl ...
... Grim economic times could cause men to seek ... to research by Omri Gillath, a social psychology professor at ... pursue short-term mating strategies when faced with a threatening environment, ... When made to think about their own death, which ...
... , THURSDAY, Oct. 13 (HealthDay News) -- ... have more relationship problems, according to a new study. ... and possessions can take a toll on couples, happiness ... Brigham Young University analyzed relationship evaluations completed by more ...
... Research (AiC: Health Research), of Virginia Tech,s National Capital ... and development agreement from the U.S. Army for neuroimaging ... option for approximately $3 million of future work based ... project team is led by Seong K. Mun, professor ...
... HealthDay Reporter , WEDNESDAY, Oct. 12 (HealthDay News) -- ... the first weeks and months following birth may predict how well ... in childhood, new research suggests. , , In a study published ... used MRI to measure the brains of 82 premature infants born ...
Cached Medicine News:Health News:Steps towards the use of adult stem cells for gene therapy 2Health News:National Jewish Health researchers awarded $13 million to evaluate treatments for toxic gases 2Health News:Permanently dismal economy could prompt men to seek more sex partners 2Health News:Couples Can Pay a Price for Materialism 2Health News:US Army awards $1.5 million for sleep research 2Health News:Preemies With Faster Brain Growth May End Up Smarter 2Health News:Preemies With Faster Brain Growth May End Up Smarter 3
(Date:9/2/2014)... Reportbuyer.com has added a new market ... for Molecular Imaging Devices https://www.reportbuyer.com/product/1923023/Global-Markets-and-Technologies-for-Molecular-Imaging-Devices.html ... The objectives of this study are to present ... for diagnostic purposes, present global market measurements of ... segments as well as forecast market and segment ...
(Date:9/2/2014)... 2, 2014 Reportbuyer.com has added a ... Global Markets for Services and Devices ... Bariatric surgery or weight loss surgery is a ... processes that deal with the surgical treatment of ... (endoluminal) and performed in both open and laparoscopic ...
(Date:9/2/2014)... -- Astellas has appointed James Kellerman as ... Americas. Kellerman will report directly to Linda Friedman ... In his new role, Kellerman will lead a team ... manage the region,s intellectual property matters, coordinating closely with ... pleased to welcome Jim to Astellas. Jim brings a ...
Breaking Medicine Technology:Global Markets and Technologies for Molecular Imaging Devices 2Global Markets and Technologies for Molecular Imaging Devices 3Global Markets and Technologies for Molecular Imaging Devices 4Global Markets and Technologies for Molecular Imaging Devices 5Global Markets and Technologies for Molecular Imaging Devices 6Global Markets and Technologies for Molecular Imaging Devices 7Global Markets and Technologies for Molecular Imaging Devices 8Global Markets and Technologies for Molecular Imaging Devices 9Global Markets and Technologies for Molecular Imaging Devices 10Global Markets and Technologies for Molecular Imaging Devices 11Global Markets and Technologies for Molecular Imaging Devices 12Global Markets and Technologies for Molecular Imaging Devices 13Global Markets and Technologies for Molecular Imaging Devices 14Global Markets and Technologies for Molecular Imaging Devices 15Global Markets and Technologies for Molecular Imaging Devices 16Global Markets and Technologies for Molecular Imaging Devices 17Global Markets and Technologies for Molecular Imaging Devices 18Global Markets and Technologies for Molecular Imaging Devices 19Global Markets and Technologies for Molecular Imaging Devices 20Global Markets and Technologies for Molecular Imaging Devices 21Global Markets and Technologies for Molecular Imaging Devices 22Global Markets and Technologies for Molecular Imaging Devices 23Global Markets and Technologies for Molecular Imaging Devices 24Global Markets and Technologies for Molecular Imaging Devices 25Bariatric Surgery: Global Markets for Services and Devices 2Bariatric Surgery: Global Markets for Services and Devices 3Bariatric Surgery: Global Markets for Services and Devices 4Bariatric Surgery: Global Markets for Services and Devices 5Bariatric Surgery: Global Markets for Services and Devices 6Bariatric Surgery: Global Markets for Services and Devices 7Bariatric Surgery: Global Markets for Services and Devices 8Bariatric Surgery: Global Markets for Services and Devices 9Bariatric Surgery: Global Markets for Services and Devices 10Bariatric Surgery: Global Markets for Services and Devices 11Bariatric Surgery: Global Markets for Services and Devices 12
... CITY, Mo.--(BUSINESS WIRE)--May 4, 2007 - New ... a combination of,COPAXONE(R) (glatiramer acetate injection) along ... (Gd)-enhancing lesions,of the brain by 63 percent ... (RRMS), as measured by,magnetic resonance imaging (MRI), ...
... in Spinal Cord,Injury Model With ZFP TF Treatment, ... Inc. announced today the presentation of preclinical,data from ... Fourteenth Annual Conference of the American Society for ... model of spinal cord,injury (SCI), demonstrate that treatment ...
Cached Medicine Technology:Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data,From Nerve Regeneration Program at American Society for Neural,Therapy and Repair Meeting 2Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data,From Nerve Regeneration Program at American Society for Neural,Therapy and Repair Meeting 3Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data,From Nerve Regeneration Program at American Society for Neural,Therapy and Repair Meeting 4
Female Compression VEST w/sleeves...
Male Support Brief...
Ideal for lower abdominal procedures. Comes with a left side separating zipper....
Arm Compression Garment...
Medicine Products: